Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories
The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The findi...
Saved in:
| Published in: | mSphere Vol. 5; no. 3 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
American Society for Microbiology
24.06.2020
|
| Subjects: | |
| ISSN: | 2379-5042, 2379-5042 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations.
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10
−4
substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5′ U/A and 3′ U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations.
IMPORTANCE
The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. |
|---|---|
| AbstractList | The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10
substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5' U/A and 3' U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations.
The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10−4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5′ U/A and 3′ U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations. IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. ABSTRACTThe pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10−4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5′ U/A and 3′ U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations.IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. ABSTRACT The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10−4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5′ U/A and 3′ U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations. IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10-4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5' U/A and 3' U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations.IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations.The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10-4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5' U/A and 3' U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations.IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its worldwide spread. To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled. Variants showed a mean of 5.5 to 9.5 nucleotide differences from each other, consistent with a midrange coronavirus substitution rate of 3 × 10 −4 substitutions/site/year. Almost one-half of sequence changes were C→U transitions, with an 8-fold base frequency normalized directional asymmetry between C→U and U→C substitutions. Elevated ratios were observed in other recently emerged coronaviruses (SARS-CoV, Middle East respiratory syndrome [MERS]-CoV), and decreasing ratios were observed in other human coronaviruses (HCoV-NL63, -OC43, -229E, and -HKU1) proportionate to their increasing divergence. C→U transitions underpinned almost one-half of the amino acid differences between SARS-CoV-2 variants and occurred preferentially in both 5′ U/A and 3′ U/A flanking sequence contexts comparable to favored motifs of human APOBEC3 proteins. Marked base asymmetries observed in nonpandemic human coronaviruses (U ≫ A > G ≫ C) and low G+C contents may represent long-term effects of prolonged C→U hypermutation in their hosts. The evidence that much of sequence change in SARS-CoV-2 and other coronaviruses may be driven by a host APOBEC-like editing process has profound implications for understanding their short- and long-term evolution. Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations. IMPORTANCE The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate provides a relatively blank canvas with which to investigate effects of mutational and editing processes imposed by the host cell. The finding that a large proportion of sequence change in SARS-CoV-2 in the initial months of the pandemic comprised C→U mutations in a host APOBEC-like context provides evidence for a potent host-driven antiviral editing mechanism against coronaviruses more often associated with antiretroviral defense. In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations. |
| Author | Simmonds, P. |
| Author_xml | – sequence: 1 givenname: P. orcidid: 0000-0002-7964-4700 surname: Simmonds fullname: Simmonds, P. organization: Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32581081$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ks9q3DAQxk1JadI0956KoJdenOqPLVs9FIJJk8BCILvpVWjl8VqLLW0leyEv0AfoI_TR-iSVdzclCfQ0YubTNz-G721yZJ2FJHlP8DkhtPzczzcteDjHOMNlSvGr5ISyQqQ5zujRk_dxchbCGmNMOOW84G-SY0bzkuCSnCS_71S_UXZA1Z-fv-7R9cMGfD8OajDOImPR0AK6Aut6CMg1aH5xN08r9z2lSNka3caxR5Xzzqqt8WOA8AVVaqq7eeVsgB8jWB0bjfNo0YLxaN46P6Q7xczZVbqIO9Hl1nXjtFb5B7Twag16cN5AeJe8blQX4OxQT5P7b5eL6jqd3V7dVBezVGcCDyldAoZCU8ZYTXIKtW6yGgSorKghF0JoJThw3pQlKchS09gRGDNGKIFGYXaa3Ox9a6fWcuNNH0mkU0buGs6vpPKD0R1I4A3HtKCKU5HVTVEKyjURuaaUZaKpo9fXvddmXPYRBezgVffM9PnEmlau3FYWjPBM0Gjw6WDgXTxgGGRvgoauUxbcGCTNSMEEJuXE_fGFdO1Gb-Opoiry5aLMRFR9eEr0D-UxClHA9wLtXQgeGqnNPgcR0HSSYDnFTh5iJ3exk3Taj198fPT-75e_y9bd-w |
| CitedBy_id | crossref_primary_10_1002_jobm_202000537 crossref_primary_10_1017_S095026882100220X crossref_primary_10_1371_journal_ppat_1009596 crossref_primary_10_1093_abt_tbab015 crossref_primary_10_1186_s12985_023_01995_3 crossref_primary_10_7717_peerj_10181 crossref_primary_10_1016_j_jsps_2021_09_006 crossref_primary_10_1371_journal_ppat_1010068 crossref_primary_10_1093_ve_veaf047 crossref_primary_10_1002_advs_202205445 crossref_primary_10_1016_j_cell_2021_08_017 crossref_primary_10_3390_v15020321 crossref_primary_10_3390_v12101095 crossref_primary_10_7717_peerj_16962 crossref_primary_10_1002_rai2_12065 crossref_primary_10_1093_nar_gkaf261 crossref_primary_10_3390_ijms232314683 crossref_primary_10_1016_j_jcvp_2021_100037 crossref_primary_10_1016_j_clim_2021_108699 crossref_primary_10_1099_jgv_0_001584 crossref_primary_10_1186_s40246_023_00515_2 crossref_primary_10_3390_microorganisms8121976 crossref_primary_10_1016_j_coviro_2023_101326 crossref_primary_10_3390_v13061084 crossref_primary_10_1111_tbed_13931 crossref_primary_10_1128_spectrum_00221_22 crossref_primary_10_1093_molbev_msac156 crossref_primary_10_1128_msphere_00913_21 crossref_primary_10_3389_fmicb_2021_665041 crossref_primary_10_1371_journal_pgen_1009175 crossref_primary_10_1007_s13353_023_00756_w crossref_primary_10_1038_s41576_021_00408_x crossref_primary_10_1016_j_virol_2020_12_018 crossref_primary_10_3389_fmed_2022_1008600 crossref_primary_10_1261_rna_079160_122 crossref_primary_10_3389_fmed_2022_835998 crossref_primary_10_1016_j_genrep_2021_101045 crossref_primary_10_1093_nargab_lqae009 crossref_primary_10_1016_j_cmi_2021_02_024 crossref_primary_10_1128_jvi_02077_21 crossref_primary_10_1080_07391102_2023_2222832 crossref_primary_10_1186_s12985_021_01633_w crossref_primary_10_1093_molbev_msaf059 crossref_primary_10_2478_acph_2025_0024 crossref_primary_10_1093_ve_veab020 crossref_primary_10_3390_v16101524 crossref_primary_10_1038_s41598_022_19067_x crossref_primary_10_1128_mSphere_00219_21 crossref_primary_10_1099_mgen_0_000751 crossref_primary_10_3390_biology10010052 crossref_primary_10_1186_s13073_024_01409_1 crossref_primary_10_3389_fimmu_2021_690416 crossref_primary_10_1038_s41423_023_01104_y crossref_primary_10_1093_bib_bbac513 crossref_primary_10_1093_ve_veab013 crossref_primary_10_1186_s12860_021_00403_4 crossref_primary_10_1093_oxfimm_iqac003 crossref_primary_10_1093_gigascience_giac079 crossref_primary_10_12688_f1000research_72896_3 crossref_primary_10_1111_febs_16230 crossref_primary_10_12688_f1000research_72896_4 crossref_primary_10_12688_f1000research_72896_1 crossref_primary_10_2217_fmb_2020_0300 crossref_primary_10_12688_f1000research_72896_2 crossref_primary_10_3390_microorganisms9050926 crossref_primary_10_1016_j_virusres_2022_198786 crossref_primary_10_1007_s13353_022_00698_9 crossref_primary_10_1186_s13073_021_00847_5 crossref_primary_10_3390_v13091800 crossref_primary_10_1371_journal_pone_0237689 crossref_primary_10_7554_eLife_66857 crossref_primary_10_1093_bib_bbab382 crossref_primary_10_1134_S0006297921030020 crossref_primary_10_3389_fvets_2021_644414 crossref_primary_10_1016_j_gpb_2020_10_003 crossref_primary_10_1016_j_heliyon_2024_e32139 crossref_primary_10_1093_ve_veae115 crossref_primary_10_3390_v15010167 crossref_primary_10_1093_nar_gkab1297 crossref_primary_10_1371_journal_pone_0273860 crossref_primary_10_1016_j_virusres_2020_198233 crossref_primary_10_1093_infdis_jiaf294 crossref_primary_10_1016_j_bbrc_2020_10_092 crossref_primary_10_15252_emmm_202114062 crossref_primary_10_1155_2022_5618222 crossref_primary_10_1038_s41576_022_00483_8 crossref_primary_10_1016_j_isci_2025_112873 crossref_primary_10_3390_cells10061557 crossref_primary_10_5662_wjm_v14_i3_89761 crossref_primary_10_1002_jmv_70353 crossref_primary_10_1093_ve_veab041 crossref_primary_10_1371_journal_pone_0247196 crossref_primary_10_3390_v14040796 crossref_primary_10_1016_j_tig_2021_07_003 crossref_primary_10_1128_mSphere_00019_21 crossref_primary_10_1038_s41525_025_00463_x crossref_primary_10_1016_j_heliyon_2022_e09449 crossref_primary_10_1186_s13062_023_00366_w crossref_primary_10_1038_s41586_021_04188_6 crossref_primary_10_3390_v13020290 crossref_primary_10_1016_j_cels_2021_09_013 crossref_primary_10_1038_s41467_020_19818_2 crossref_primary_10_1126_science_abe5901 crossref_primary_10_1038_s44318_024_00314_y crossref_primary_10_3390_v13030394 crossref_primary_10_1016_j_virol_2022_01_011 crossref_primary_10_1093_nar_gkaf503 crossref_primary_10_1093_nar_gkac1238 crossref_primary_10_3389_fcimb_2024_1476605 crossref_primary_10_1016_j_jiac_2022_01_019 crossref_primary_10_1186_s12985_023_01982_8 crossref_primary_10_3390_genes12060826 crossref_primary_10_1186_s12864_022_08664_9 crossref_primary_10_1016_j_virol_2025_110607 crossref_primary_10_1002_jmv_29128 crossref_primary_10_1186_s13059_023_02881_5 crossref_primary_10_7759_cureus_33316 crossref_primary_10_1016_j_isci_2023_108031 crossref_primary_10_1126_science_abp8337 crossref_primary_10_1007_s00239_021_10008_2 crossref_primary_10_1093_molbev_msac028 crossref_primary_10_1016_j_banm_2021_11_002 crossref_primary_10_1016_j_micpath_2024_106796 crossref_primary_10_3390_pathogens9110912 crossref_primary_10_1371_journal_pbio_3001115 crossref_primary_10_1093_molbev_msaa247 crossref_primary_10_1093_molbev_msac029 crossref_primary_10_1093_emph_eoab019 crossref_primary_10_12998_wjcc_v9_i1_1 crossref_primary_10_1371_journal_pone_0255169 crossref_primary_10_3390_life11080734 crossref_primary_10_1038_s12276_021_00658_z crossref_primary_10_1093_nar_gkaf447 crossref_primary_10_3390_pathogens11060662 crossref_primary_10_1016_j_gene_2022_147020 crossref_primary_10_1016_j_jinf_2024_106150 crossref_primary_10_1186_s12879_025_11355_x crossref_primary_10_3390_ijms24109072 crossref_primary_10_3390_v16071141 crossref_primary_10_1038_s41579_023_00878_2 crossref_primary_10_1111_1462_2920_15487 crossref_primary_10_1002_wrna_1679 crossref_primary_10_1371_journal_pcbi_1011795 crossref_primary_10_12688_f1000research_52540_3 crossref_primary_10_12688_f1000research_52540_2 crossref_primary_10_3390_v15051152 crossref_primary_10_12688_f1000research_52540_1 crossref_primary_10_1016_j_virol_2024_110366 crossref_primary_10_1016_j_virusres_2022_198753 |
| Cites_doi | 10.1038/nature01707 10.1016/j.virol.2015.03.012 10.1186/1471-2148-12-71 10.1371/journal.pbio.0020275 10.1056/NEJMoa2001017 10.1038/srep39100 10.1126/sciadv.abb5813 10.1186/1756-0500-5-50 10.1016/j.antiviral.2019.03.005 10.1038/nature01709 10.1038/s41586-020-2012-7 10.1186/s13059-019-1651-1 10.1016/0042-6822(92)91195-z 10.1186/s13059-019-1659-6 10.1128/JVI.01296-07 10.1038/ncomms7881 10.1126/science.1100658 10.1038/s41586-020-2008-3 10.1016/j.meegid.2018.04.031 10.1016/j.virusres.2014.11.031 10.1073/pnas.91.8.3092 10.1016/j.virol.2010.12.004 10.1016/j.prevetmed.2015.11.001 10.1186/1471-2164-14-610 10.1099/vir.0.038919-0 10.1056/NEJMoa2001316 10.1093/molbev/mst197 10.1128/jvi.78.3.1602-1603.2004 10.1038/s41598-018-24448-2 10.1093/nar/gkz1164 10.1128/mBio.01062-13 10.1016/j.virol.2007.08.010 10.1111/j.1863-2378.2012.01528.x 10.1371/journal.ppat.1003565 10.1371/journal.pone.0030036 10.1128/JVI.79.5.3223-3225.2005 10.1016/s0092-8674(03)00423-9 10.1016/bs.aivir.2018.01.001 10.1074/jbc.M602367200 10.1371/journal.ppat.1000896 |
| ContentType | Journal Article |
| Copyright | Copyright © 2020 Simmonds. Copyright © 2020 Simmonds. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2020 Simmonds. 2020 Simmonds |
| Copyright_xml | – notice: Copyright © 2020 Simmonds. – notice: Copyright © 2020 Simmonds. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2020 Simmonds. 2020 Simmonds |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1128/mSphere.00408-20 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | C→U Hypermutation in SARS Coronavirus 2 |
| EISSN | 2379-5042 |
| ExternalDocumentID | oai_doaj_org_article_e6f60272a6294df78926c195c22349fd PMC7316492 32581081 10_1128_mSphere_00408_20 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Wellcome Trust grantid: WT103767MA – fundername: Wellcome Trust – fundername: ; grantid: WT103767MA |
| GroupedDBID | 0R~ 53G 5VS 7X7 8FE 8FH 8FI 8FJ AAFWJ AAGFI AAUOK AAYXX ABUWG ADBBV AFFHD AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK EBS FRP FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE KQ8 LK8 M48 M7P M~E O9- OK1 PGMZT PHGZM PHGZT PIMPY PQGLB PQQKQ PROAC R9- RHI RPM RSF UKHRP ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC COVID DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c490t-2be0e7c2333d152edcf4de9ea47de5999ca96e66f88171bc299c90033121efa03 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 147 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000569211400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2379-5042 |
| IngestDate | Fri Oct 03 12:50:32 EDT 2025 Tue Nov 04 01:57:24 EST 2025 Thu Oct 02 11:05:28 EDT 2025 Tue Oct 07 06:58:49 EDT 2025 Thu Apr 03 07:05:44 EDT 2025 Sat Nov 29 03:33:44 EST 2025 Tue Nov 18 22:11:25 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | COVID-19 SARS-CoV-2 APOBEC SARS coronavirus SARS coronavirus 2 hypermutation |
| Language | English |
| License | Copyright © 2020 Simmonds. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c490t-2be0e7c2333d152edcf4de9ea47de5999ca96e66f88171bc299c90033121efa03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Citation Simmonds P. 2020. Rampant C→U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories. mSphere 5:e00408-20. https://doi.org/10.1128/mSphere.00408-20. |
| ORCID | 0000-0002-7964-4700 |
| OpenAccessLink | https://doaj.org/article/e6f60272a6294df78926c195c22349fd |
| PMID | 32581081 |
| PQID | 2429459849 |
| PQPubID | 2045592 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e6f60272a6294df78926c195c22349fd pubmedcentral_primary_oai_pubmedcentral_nih_gov_7316492 proquest_miscellaneous_2417390180 proquest_journals_2429459849 pubmed_primary_32581081 crossref_citationtrail_10_1128_mSphere_00408_20 crossref_primary_10_1128_mSphere_00408_20 |
| PublicationCentury | 2000 |
| PublicationDate | 20200624 |
| PublicationDateYYYYMMDD | 2020-06-24 |
| PublicationDate_xml | – month: 6 year: 2020 text: 20200624 day: 24 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Washington – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | mSphere |
| PublicationTitleAlternate | mSphere |
| PublicationYear | 2020 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 Mavian C (e_1_3_2_6_2) 2020 |
| References_xml | – ident: e_1_3_2_20_2 doi: 10.1038/nature01707 – ident: e_1_3_2_24_2 doi: 10.1016/j.virol.2015.03.012 – ident: e_1_3_2_25_2 doi: 10.1186/1471-2148-12-71 – ident: e_1_3_2_27_2 doi: 10.1371/journal.pbio.0020275 – ident: e_1_3_2_4_2 doi: 10.1056/NEJMoa2001017 – ident: e_1_3_2_35_2 doi: 10.1038/srep39100 – ident: e_1_3_2_37_2 doi: 10.1126/sciadv.abb5813 – ident: e_1_3_2_41_2 doi: 10.1186/1756-0500-5-50 – ident: e_1_3_2_31_2 doi: 10.1016/j.antiviral.2019.03.005 – ident: e_1_3_2_21_2 doi: 10.1038/nature01709 – ident: e_1_3_2_3_2 doi: 10.1038/s41586-020-2012-7 – ident: e_1_3_2_34_2 doi: 10.1186/s13059-019-1651-1 – ident: e_1_3_2_11_2 doi: 10.1016/0042-6822(92)91195-z – ident: e_1_3_2_18_2 doi: 10.1186/s13059-019-1659-6 – ident: e_1_3_2_9_2 doi: 10.1128/JVI.01296-07 – ident: e_1_3_2_33_2 doi: 10.1038/ncomms7881 – ident: e_1_3_2_29_2 doi: 10.1126/science.1100658 – ident: e_1_3_2_5_2 doi: 10.1038/s41586-020-2008-3 – ident: e_1_3_2_13_2 doi: 10.1016/j.meegid.2018.04.031 – ident: e_1_3_2_38_2 doi: 10.1016/j.virusres.2014.11.031 – ident: e_1_3_2_23_2 doi: 10.1073/pnas.91.8.3092 – ident: e_1_3_2_19_2 doi: 10.1016/j.virol.2010.12.004 – ident: e_1_3_2_14_2 doi: 10.1016/j.prevetmed.2015.11.001 – ident: e_1_3_2_17_2 doi: 10.1186/1471-2164-14-610 – ident: e_1_3_2_30_2 doi: 10.1099/vir.0.038919-0 – ident: e_1_3_2_2_2 doi: 10.1056/NEJMoa2001316 – ident: e_1_3_2_42_2 doi: 10.1093/molbev/mst197 – ident: e_1_3_2_10_2 doi: 10.1128/jvi.78.3.1602-1603.2004 – ident: e_1_3_2_32_2 doi: 10.1038/s41598-018-24448-2 – ident: e_1_3_2_36_2 doi: 10.1093/nar/gkz1164 – ident: e_1_3_2_15_2 doi: 10.1128/mBio.01062-13 – ident: e_1_3_2_16_2 doi: 10.1016/j.virol.2007.08.010 – ident: e_1_3_2_39_2 doi: 10.1111/j.1863-2378.2012.01528.x – year: 2020 ident: e_1_3_2_6_2 article-title: Regaining perspective on SARS-CoV-2 molecular tracing and its implications publication-title: medRxiv – ident: e_1_3_2_7_2 doi: 10.1371/journal.ppat.1003565 – ident: e_1_3_2_26_2 doi: 10.1371/journal.pone.0030036 – ident: e_1_3_2_12_2 doi: 10.1128/JVI.79.5.3223-3225.2005 – ident: e_1_3_2_22_2 doi: 10.1016/s0092-8674(03)00423-9 – ident: e_1_3_2_40_2 doi: 10.1016/bs.aivir.2018.01.001 – ident: e_1_3_2_28_2 doi: 10.1074/jbc.M602367200 – ident: e_1_3_2_8_2 doi: 10.1371/journal.ppat.1000896 |
| SSID | ssj0001626676 |
| Score | 2.5390484 |
| Snippet | The wealth of accurately curated sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long genome, and its low substitution rate... The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology following its... ABSTRACTThe pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology... ABSTRACT The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has motivated an intensive analysis of its molecular epidemiology... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Amino acid sequence Antiretroviral drugs Antiviral drugs APOBEC APOBEC Deaminases Asymmetry Base Composition - genetics Base Sequence - genetics Betacoronavirus - genetics Coronaviridae coronavirus Coronavirus Infections - pathology Coronaviruses COVID-19 Cytidine Deaminase - genetics Cytosine - analysis Datasets Disease transmission Divergence Ecological and Evolutionary Science Epidemics Epidemiology Evolution Genome, Viral - genetics Genomes Humans hypermutation Long-term effects Mathematical models Middle East Respiratory Syndrome Coronavirus - genetics Molecular modelling Mutation Pandemics Pneumonia, Viral - pathology Polymorphism, Single Nucleotide - genetics Reversion RNA polymerase SARS SARS coronavirus 2 SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Severe acute respiratory syndrome-related coronavirus - genetics Uracil - analysis Zoonoses |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NjtMwELagCxIX_n8CCzISFw6mjuPENhe0G3XZAyqrtov2FiWOvVtEkyVpK-0L8AA8Ao_Gk-BJ3e4Wob1wihRPlFH82fPNjDOD0JvQWlvQ0pDSCk64jiOiioiSQkgtEhWy0JRdswkxHMqTE3XkA26tP1a53hO7jbqsNcTI-86UKB4rydWH8-8EukZBdtW30LiJdqBSGe-hnf3B8Gh0GWVxfD0Rm_wkk_3ZGH7XN-8AvYCRLXvUle3_F9f8-8jkFRt0cO9_tb-P7nr2ifdWcHmAbpjqIbq96kd58Qj9GkH5xWqO098_fh7jQ-ejNrPFKlmPpxV2ZBF_NFU9My2uLR7vjcYkrb8QhvOqxJ-BS-IUSiLky2mzaE37Hqc5XLvx9MrBbey4Mp5AkgKPz5wHQDqJT3V1SibunXiw9Esiby6ws6dfu-SC8-ofo-ODwSQ9JL6JA9Fc0TlhhaFGaBZFUem4gvuClpdGmZyL0sSOnupcJSZJrJShCAvtzKOG6GoEMLE5jZ6gXlVX5hnCVFNTCmmUM6lc5nHhXCdNqY5lbkUh4wD111OZaV_hHBptfMs6T4fJzE9-1k1-xmiA3m6eOF9V97hGdh_QsZGDutzdjbo5zfwyz0xiE-foszxx8-3gLxVLdKhi7VgYV7YM0O4aH5nfLNrsEhwBer0Zdssccjd5ZeoFyIQCwlPS6fF0BcWNJhGLZeioXYDEFki3VN0eqaZnXSlx6FvGFXt-vVov0B0GYQaaEMZ3UW_eLMxLdEsv59O2eeXX3B_9wjs6 priority: 102 providerName: ProQuest |
| Title | Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32581081 https://www.proquest.com/docview/2429459849 https://www.proquest.com/docview/2417390180 https://pubmed.ncbi.nlm.nih.gov/PMC7316492 https://doaj.org/article/e6f60272a6294df78926c195c22349fd |
| Volume | 5 |
| WOSCitedRecordID | wos000569211400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: M~E dateStart: 20160101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: M7P dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2379-5042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001626676 issn: 2379-5042 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELZgAYkL4p_CUhmJCwdTx3Fim9tu1GWRoFRtF5VT5Dg2W0QT1D9pX4AH4BF4NJ6EsZOtWoTgwiWRbCdxPJ8z33icGYSeR865gpaWlE5wwk0SE1XElBRCGpGqiEW2DMkmxGAgp1M13En15feENeGBm4Hr2dSlYDoxnTLF4YZSsdREKjGg17hypf_6AuvZMabC6grw9FRs_ZJM9uZj_5u-felR67Gxp4dCuP4_cczft0ru6J6T2-hWSxrxUdPZO-iKre6iG00ayYt76MfIR02sVjj7-e37GT4F03IxXzc-djyrMHA8_NpW9dwuce3w-Gg0Jln9gTCsqxK_9xQQZz6Sgd7MFuulXb7CmfbnUJ_t7LfGQHHxxPsW8PgciDsJLd7W1ScygWfi_qZFsl5cYFCDn4NPAIzx--jspD_JTkmbe4EYruiKsMJSKwyL47gEFQ8D4HhpldVclDYBVmm0Sm2aOikjERUGtJrxi6Kxl67TNH6ADqq6so8QpobaUkirQBNyqZMCLB5DqUmkdqKQSQf1LiWRmzYwuc-P8SUPBgqTeSu7PMguZ7SDXmyv-NoE5fhL22Mv3G07H047FADI8hZk-b9A1kGHl9DI2zm-zIHcKJ4oyVUHPdtWw-z0Lhdd2Xrt20TCrypJ6MfDBknbnsQskREwsg4Sexjb6-p-TTU7DxHAfboxrtjj__FuT9BN5tcQaEoYP0QHq8XaPkXXzWY1Wy666KqYinCUXXTtuD8YjrphqnX9LtkhlA3fvBt-_AUShjDW |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3dbtMwFLbGAMEN_z-FAUaCCy5MHefHNhJCI2x0Wilo7VDvQuI4WxFNRtIW9QV4AB6BB-CheBJ8nLRbEdrdLriqVDvtUfKd4-_85ByEnjhZliU01STNuEc85btEJi4lCReKB9Jhjk7tsAne64nhUH5YQ78W78JAWeXCJlpDnRYKYuRtc5RIz5fCk6-OvhKYGgXZ1cUIjRoWu3r-zbhs1cudN-b5PmVse2sQdkgzVYAoT9IJYYmmmivmum5qDi-dqsxLtdSxx1PtG76kYhnoIMiEcLiTKGOvFYT7XJA7i6lrfvccOm_E4VBCxof8OKZjvIOAL7OhTLTHfWgOoJ-DrgAiV04_OyTgX8z27wLNEyfe9tX_7V5dQ1cabo03a2W4jtZ0fgNdrKdtzm-in3vQXDKf4PD39x_7uGM88HI8rUsR8CjHhgrjtzovxrrCRYb7m3t9EhYfCcNxnuL3wJRxCA0f4tmonFa6eoHDGD7teniiLB0bTwAPIAWD-4fGvyF2R7fID8jA_CfemjUKH5dzbNjCZ5s6GenqFto_kxt0G63nRa7vIkwV1SkXWhrC4InYT4xjqChVvogzngi_hdoL6ESq6d8OY0S-RNaPYyJqwBZZsEWMttCz5RVHde-SU_a-BjQu90HXcftFUR5EjRGLdJAFlHEWBwZfRrmFZIFypK8Mx_RklrbQxgKPUWMKq-gYjC30eLlsjBhkpuJcF1PY43AIvgkjx50a-ktJXOYLxxDXFuIrSrEi6upKPjq0jdJhKpsn2b3TxXqELnUG77pRd6e3ex9dZhBQoQFh3gZan5RT_QBdULPJqCofWm3H6NNZq8wf-SmXKw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3dbtMwFLbGBogb_n8KA4wEF1yYOs6PbSSEtq5l06ZSrd20u5A49lZEk5G0RX0BHoBH4DF4HJ6E4yTtVoR2twuuKsVO6iTnO_7OT85B6KVjjIlpokliuEc85btExi4lMReKB9Jhjk7KZhO82xVHR7K3gn7Nv4WxaZVznVgq6iRT1kfehK1Eer4UnmyaOi2it9V5f_qV2A5SNtI6b6dRiciunn0D8614t7MF7_oVY532oLVN6g4DRHmSjgmLNdVcMdd1E9jIdKKMl2ipI48n2gfupCIZ6CAwQjjciRXobmVdf669BxNRF657Ba1xIBmArrXNdre3f-bhAVsh4IvYKBPNUd-WCtBvLHKsfC7thWXLgH_x3L_TNc_tf51b__OTu41u1qwbb1QwuYNWdHoXXav6cM7uoZ_7tuxkOsat399_HOBtsM3z0aRKUsDDFANJxh90mo10gTOD-xv7fdLKDgnDUZrgj5ZD45YtBRFNh_mk0MVb3IrsbzneOpewjsFGwAMbnMH9E7B8SDljL0uPyQD-E7entSqI8hkGHvG5DKoMdXEfHVzKA3qAVtMs1Y8QporqhAstgUp4IvJjMBkVpcoXkeGx8BuoORejUNWV3W2DkS9haeExEdaCF5aCFzLaQK8XZ5xWVU0umLtpJXMxz9YjLw9k-XFYq7dQByagjLMoAFkD2AsAhHKkr4B9etIkDbQ-l82wVpJFeCaYDfRiMQzqzcasolRnEzvH4dYtJ2AdDysYLFbiMl84QGkbiC8BZGmpyyPp8KQsoW77tXmSPb54Wc_RdUBKuLfT3X2CbjDraaEBYd46Wh3nE_0UXVXT8bDIn9XQx-jTZWPmD15HoUw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rampant+C%E2%86%92U+Hypermutation+in+the+Genomes+of+SARS-CoV-2+and+Other+Coronaviruses%3A+Causes+and+Consequences+for+Their+Short-+and+Long-Term+Evolutionary+Trajectories&rft.jtitle=mSphere&rft.au=Simmonds%2C+P&rft.date=2020-06-24&rft.eissn=2379-5042&rft.volume=5&rft.issue=3&rft_id=info:doi/10.1128%2FmSphere.00408-20&rft_id=info%3Apmid%2F32581081&rft.externalDocID=32581081 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5042&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5042&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5042&client=summon |